|Integrative Cancer Immunology · 15 Rue de l'Ecole de Medecine, 75006 Paris, France
Tel +33 1 4427 9101 · Fax +33 1 4427 8117 · URL http://www.ici.upmc.fr/index.shtml
as a new possible approach for cancer classification.
Head of the Laboratory of Integrative Cancer Immunology
INSERM UMRS1138, Paris, France
Over the past few years, the area of immune regulation at the level of the tumor microenvironment has gained a forefront position in cancer research. At the same time, advances have been made in the development of an immune score, called "Immunoscore"®, as a prognostic factor.
In an effort to promote the Immunoscore in routine clinical settings, a worldwide task force was initiated by Dr Galon.
The working group composed of international expert pathologists and immunologists identified a strategy for the organization of a worldwide participation by various groups for the validation of the Immunoscore.
July, 2014 Natural and therapy-induced anticancer immunosurveillance: the Immunoscore, Paris, France
January, 2014 Tumor immunology symposium: The Immunoscore in cancer, Doha, Qatar
December, 2013 Melanoma bridge meeting: The Immunoscore in cancer, Naples, Italy
November, 2013 SITC annual meeting organizer and chairman: Biomarkers in cancer, Washington DC, USA
December, 2012 The first Meeting on the Immunoscoring will be held in Naples, Italy
13.03.2012 The Society for ImmunoTherapy of Cancer and Fondazione Melanoma organize a task force on Immunoscoring in Naples, Italy